KLK3 and neoplasm: Given the evidence of impact of tumor grade and PSA level on the outcomes of advanced disease, further refinements in the sub-classification of advanced disease may also be achieved by incorporating grade group and PSA levels into the staging of advanced disease (just like it was incorporated into the staging of clinically localized disease) [5].